BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 17375873)

  • 1. Role of molecular markers in diagnosis and prognosis of renal cell carcinoma.
    Martignoni G; Brunelli M; Gobbo S; Remo A; Ficarra V; Cossu-Rocca P; Pea M; Chilosi M; Menestrina F; Cheng L
    Anal Quant Cytol Histol; 2007 Feb; 29(1):41-9. PubMed ID: 17375873
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clear Cell Renal Cell Carcinoma With Borderline Features of Clear Cell Papillary Renal Cell Carcinoma: Combined Morphologic, Immunohistochemical, and Cytogenetic Analysis.
    Williamson SR; Gupta NS; Eble JN; Rogers CG; Michalowski S; Zhang S; Wang M; Grignon DJ; Cheng L
    Am J Surg Pathol; 2015 Nov; 39(11):1502-10. PubMed ID: 26457355
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fluorescence in situ hybridization as an adjunct tool in the diagnosis of primary and metastatic renal cell carcinoma in fine needle aspiration specimens.
    Kos Z; Williams PA; Belanger EC; Mai KT
    Diagn Cytopathol; 2014 Dec; 42(12):1013-23. PubMed ID: 24692327
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clear cell tubulopapillary renal cell carcinoma: a study of 36 distinctive low-grade epithelial tumors of the kidney.
    Aydin H; Chen L; Cheng L; Vaziri S; He H; Ganapathi R; Delahunt B; Magi-Galluzzi C; Zhou M
    Am J Surg Pathol; 2010 Nov; 34(11):1608-21. PubMed ID: 20924276
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cystic and necrotic papillary renal cell carcinoma: prognosis, morphology, immunohistochemical, and molecular-genetic profile of 10 cases.
    Peckova K; Martinek P; Pivovarcikova K; Vanecek T; Alaghehbandan R; Prochazkova K; Montiel DP; Hora M; Skenderi F; Ulamec M; Rotterova P; Daum O; Ferda J; Davidson W; Ondic O; Dubova M; Michal M; Hes O
    Ann Diagn Pathol; 2017 Feb; 26():23-30. PubMed ID: 28038707
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The usefulness of immunohistochemical markers in the differential diagnosis of renal neoplasms.
    Zhou M; Roma A; Magi-Galluzzi C
    Clin Lab Med; 2005 Jun; 25(2):247-57. PubMed ID: 15848735
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biphasic alveolosquamoid renal carcinoma: a histomorphological, immunohistochemical, molecular genetic, and ultrastructural study of a distinctive morphologic variant of renal cell carcinoma.
    Petersson F; Bulimbasic S; Hes O; Slavik P; Martínek P; Michal M; Gomolčáková B; Hora M; Damjanov I
    Ann Diagn Pathol; 2012 Dec; 16(6):459-69. PubMed ID: 23036259
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cystic Renal Oncocytoma and Tubulocystic Renal Cell Carcinoma: Morphologic and Immunohistochemical Comparative Study.
    Skenderi F; Ulamec M; Vranic S; Bilalovic N; Peckova K; Rotterova P; Kokoskova B; Trpkov K; Vesela P; Hora M; Kalusova K; Sperga M; Perez Montiel D; Alvarado Cabrero I; Bulimbasic S; Branzovsky J; Michal M; Hes O
    Appl Immunohistochem Mol Morphol; 2016 Feb; 24(2):112-9. PubMed ID: 26180933
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fluorescent cytogenetics of renal cell neoplasms.
    Brunelli M; Gobbo S; Cossu-Rocca P; Cheng L; Ficarra V; Novara G; Menestrina F; Chilosi M; Martignoni G
    Pathologica; 2008 Dec; 100(6):454-60. PubMed ID: 19475886
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Renal tubulocystic carcinoma is closely related to papillary renal cell carcinoma: implications for pathologic classification.
    Zhou M; Yang XJ; Lopez JI; Shah RB; Hes O; Shen SS; Li R; Yang Y; Lin F; Elson P; Sercia L; Magi-Galluzzi C; Tubbs R
    Am J Surg Pathol; 2009 Dec; 33(12):1840-9. PubMed ID: 19898225
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Validation of 34betaE12 immunoexpression in clear cell papillary renal cell carcinoma as a sensitive biomarker.
    Martignoni G; Brunelli M; Segala D; Munari E; Gobbo S; Cima L; Borze I; Wirtanen T; Sarhadi VK; Atanesyan L; Savola S; Barzon L; Masi G; Fassan M; Eble JN; Bohling T; Cheng L; Delahunt B; Knuutila S
    Pathology; 2017 Jan; 49(1):10-18. PubMed ID: 27923499
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Renal cell neoplasms of oncocytosis have distinct morphologic, immunohistochemical, and cytogenetic profiles.
    Gobbo S; Eble JN; Delahunt B; Grignon DJ; Samaratunga H; Martignoni G; Zhang S; Wang M; Brunelli M; Cossu-Rocca P; Cheng L
    Am J Surg Pathol; 2010 May; 34(5):620-6. PubMed ID: 20305535
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The diagnostic utility of MOC31, BerEP4, RCC marker and CD10 in the classification of renal cell carcinoma and renal oncocytoma: an immunohistochemical analysis of 328 cases.
    Pan CC; Chen PC; Ho DM
    Histopathology; 2004 Nov; 45(5):452-9. PubMed ID: 15500648
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Study on clinicopathologic features and immunophenotype of 114 cases of renal cell carcinoma].
    Zou H; Pang LJ; Hu WH; Li F; Li HA; Jiang JF; Liang WH; Sun ZZ; Wang C; Lang JY
    Zhonghua Bing Li Xue Za Zhi; 2008 Nov; 37(11):726-31. PubMed ID: 19094705
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An immunohistochemical approach to the differential diagnosis of renal tumors.
    Skinnider BF; Amin MB
    Semin Diagn Pathol; 2005 Feb; 22(1):51-68. PubMed ID: 16512599
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chromophobe renal cell carcinoma with neuroendocrine and neuroendocrine-like features. Morphologic, immunohistochemical, ultrastructural, and array comparative genomic hybridization analysis of 18 cases and review of the literature.
    Peckova K; Martinek P; Ohe C; Kuroda N; Bulimbasic S; Condom Mundo E; Perez Montiel D; Lopez JI; Daum O; Rotterova P; Kokoskova B; Dubova M; Pivovarcikova K; Bauleth K; Grossmann P; Hora M; Kalusova K; Davidson W; Slouka D; Miroslav S; Buzrla P; Hynek M; Michal M; Hes O
    Ann Diagn Pathol; 2015 Aug; 19(4):261-8. PubMed ID: 26031603
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mucinous spindle and tubular renal cell carcinoma: analysis of chromosomal aberration pattern of low-grade, high-grade, and overlapping morphologic variant with papillary renal cell carcinoma.
    Peckova K; Martinek P; Sperga M; Montiel DP; Daum O; Rotterova P; Kalusová K; Hora M; Pivovarcikova K; Rychly B; Vranic S; Davidson W; Vodicka J; Dubová M; Michal M; Hes O
    Ann Diagn Pathol; 2015 Aug; 19(4):226-31. PubMed ID: 26009022
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mucinous tubular and spindle cell carcinoma and solid variant papillary renal cell carcinoma: a clinicopathologic comparative analysis of four cases with similar molecular genetics datum.
    Zhang Y; Yong X; Wu Q; Wang X; Zhang Q; Wu S; Yu D
    Diagn Pathol; 2014 Dec; 9():194. PubMed ID: 25476569
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clear cell papillary renal cell carcinoma: a distinct histopathologic and molecular genetic entity.
    Gobbo S; Eble JN; Grignon DJ; Martignoni G; MacLennan GT; Shah RB; Zhang S; Brunelli M; Cheng L
    Am J Surg Pathol; 2008 Aug; 32(8):1239-45. PubMed ID: 18594469
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Renal Neoplasms With Overlapping Features of Clear Cell Renal Cell Carcinoma and Clear Cell Papillary Renal Cell Carcinoma: A Clinicopathologic Study of 37 Cases From a Single Institution.
    Dhakal HP; McKenney JK; Khor LY; Reynolds JP; Magi-Galluzzi C; Przybycin CG
    Am J Surg Pathol; 2016 Feb; 40(2):141-54. PubMed ID: 26752401
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.